- BNF:
- Not listed
- Status:
- Red
- Decision Date:
- July 2016
Comments
RED1,2,3 : NICE TA396, trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma. (Decision date - July 2016)
NHS England is the responsible commissioner.
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again